Enlivex Therapeutics Ltd. (ENLV) Financials
ENLV Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-09-30 | 46.9 million | 8.2 million |
2023-06-30 | 53.0 million | 8.7 million |
2023-03-31 | 60.0 million | 9.4 million |
2022-12-31 | 67.6 million | 10.8 million |
ENLV Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-09-30 | -5.5 million | 407000 |
2023-06-30 | -7.1 million | 511000 |
2023-03-31 | -5.9 million | 633000 |
2022-12-31 | -7.4 million | 757000 |
ENLV Net Income
No data available :(
ENLV Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-09-30 | 30.5 million | - | 4.5 million |
2023-06-30 | 28.9 million | - | 4.4 million |
2023-03-31 | 36.0 million | - | 4.7 million |
2022-12-31 | 48.1 million | - | 653000 |
ENLV Shares Outstanding
ENLV Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-09-30 | 29000 | 4.3 million | 1.3 million | - |
2023-06-30 | 38000 | 5.0 million | 1.6 million | - |
2023-03-31 | 162000 | 5.2 million | 1.6 million | - |
2022-12-31 | 2.6 million | 5.7 million | 1.7 million | - |
ENLV Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-09-30 | - | 214000 |
2023-06-30 | - | - |
2023-03-31 | - | 209000 |
2022-12-31 | - | - |
ENLV
Price: $1.58
52 week price:
Earnings Per Share: -1.47 USD
P/E Ratio: -2.18
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 21300
Market Capitalization: 24.2 million